Life Science IAT January 19

Top of the news:

Pharm Exec is predicting how marketing strategies for healthcare service providers will change in 2022.

Political:

President Biden is requiring private insurers to cover eight at-home COVID-19 tests per covered person per month.

The Centers for Medicare & Medicaid Services have announced this past Tuesday, January 11 that they will be limiting Medicare’s coverage of the controversial Aduhelm to patients who partake in a clinical trial.

Social:

A new report from healthcare focused technology provider Indegene shows that roughly 62% of health care providers describe themselves as “overwhelmed” by the product related promotional content they receive from drugmakers – a potential side effect of pharma marketers being driven online by the pandemic.

Student workers at Columbia University have ended their ten week strike with an agreement that improves their health benefits and raises their wages.

Environmental:

UK Research and Innovation identified some potential Net-Zero medical jobs that may be available in the future.

Professional Development:

 Here’s what courageous leaders do.

Economic:

An analysis by Kaufman Hall said that while there were far less mergers and acquisitions of health systems and hospitals in 2021, there were larger ones.

Weed all about it: Pfizer has purchased cannabinoid therapy focused biotech Arena Pharmaceuticals.

Technology:

Surgeons at the University of Maryland Medical Center have completed the first successful transplant of a genetically modified pig’s heart into a human body.

AI drug discovery company PostEra is shaking up the industry, enough that it signed some deals with Pfizer.

Legal:

Elizabeth Holmes will be sentenced this September.

Holmes’ attorneys are expected to fight their client’s guilty verdicts, but the few not guilty verdicts could put issues in the way of that.